CarbadoxCAS# 6804-07-5 |
- Baicalein
Catalog No.:BCN5599
CAS No.:491-67-8
- Luteolin
Catalog No.:BCN5600
CAS No.:491-70-3
- Chloroquine diphosphate
Catalog No.:BCC3915
CAS No.:50-63-5
- Apigenin
Catalog No.:BCN5658
CAS No.:520-36-5
- Vitamin D3
Catalog No.:BCN2186
CAS No.:67-97-0
- D-64131
Catalog No.:BCC1510
CAS No.:74588-78-6
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 6804-07-5 | SDF | Download SDF |
PubChem ID | 2553 | Appearance | Powder |
Formula | C11H10N4O4 | M.Wt | 262.22 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | DMSO : 6 mg/mL (22.88 mM; Need ultrasonic) | ||
Chemical Name | methyl N-[(1-hydroxy-4-oxidoquinoxalin-4-ium-2-ylidene)methylimino]carbamate | ||
SMILES | COC(=O)N=NC=C1C=[N+](C2=CC=CC=C2N1O)[O-] | ||
Standard InChIKey | BPMVRAQIQQEBLN-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C11H10N4O4/c1-19-11(16)13-12-6-8-7-14(17)9-4-2-3-5-10(9)15(8)18/h2-7,18H,1H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Carbadox Dilution Calculator
Carbadox Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.8136 mL | 19.068 mL | 38.1359 mL | 76.2718 mL | 95.3398 mL |
5 mM | 0.7627 mL | 3.8136 mL | 7.6272 mL | 15.2544 mL | 19.068 mL |
10 mM | 0.3814 mL | 1.9068 mL | 3.8136 mL | 7.6272 mL | 9.534 mL |
50 mM | 0.0763 mL | 0.3814 mL | 0.7627 mL | 1.5254 mL | 1.9068 mL |
100 mM | 0.0381 mL | 0.1907 mL | 0.3814 mL | 0.7627 mL | 0.9534 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Carbadox is a drug that combats bacterial infection in swine, particularly swine dysentery.
- Pulsatilla saponin D
Catalog No.:BCN8526
CAS No.:68027-15-6
- Pulsatilla saponin H
Catalog No.:BCN8181
CAS No.:68027-14-5
- Magnocurarine
Catalog No.:BCN3839
CAS No.:6801-40-7
- Hydroxyprogesterone
Catalog No.:BCC8996
CAS No.:68-96-2
- Ac-Pro-OH
Catalog No.:BCC3017
CAS No.:68-95-1
- Hypoxanthine
Catalog No.:BCC5324
CAS No.:68-94-0
- Metamizole sodium
Catalog No.:BCC9024
CAS No.:68-89-3
- Hydroxyzine
Catalog No.:BCC5209
CAS No.:68-88-2
- Sulfadiazine
Catalog No.:BCC3859
CAS No.:68-35-9
- Vitamin A
Catalog No.:BCN8349
CAS No.:68-26-8
- Norethindrone
Catalog No.:BCC4811
CAS No.:68-22-4
- Vitamin B12
Catalog No.:BCC4878
CAS No.:68-19-9
- (Z)-4-Hydroxytamoxifen
Catalog No.:BCC6015
CAS No.:68047-06-3
- Escin
Catalog No.:BCC8323
CAS No.:6805-41-0
- Platyconic acid A
Catalog No.:BCN3239
CAS No.:68051-23-0
- EMPA
Catalog No.:BCC6226
CAS No.:680590-49-2
- Megastigm-7-ene-3,5,6,9-tetraol
Catalog No.:BCN5169
CAS No.:680617-50-9
- Trifolirhizin
Catalog No.:BCN4237
CAS No.:6807-83-6
- Norfloxacin hydrochloride
Catalog No.:BCC4230
CAS No.:68077-27-0
- Boc-Phe(4-Cl)-OH
Catalog No.:BCC3172
CAS No.:68090-88-0
- 4',5,7-Trihydroxy-6-prenylflavone
Catalog No.:BCN4238
CAS No.:68097-13-2
- Bepridil hydrochloride
Catalog No.:BCC7864
CAS No.:68099-86-5
- 13-Dehydroxyindaconintine
Catalog No.:BCN8403
CAS No.:681-18-9
- AICAR phosphate
Catalog No.:BCC4220
CAS No.:681006-28-0
Carbadox has both temporary and lasting effects on the swine gut microbiota.[Pubmed:24959163]
Front Microbiol. 2014 Jun 10;5:276.
Antibiotics are used in livestock and poultry production to treat and prevent disease as well as to promote animal growth. Carbadox is an in-feed antibiotic that is widely used in swine production to prevent dysentery and to improve feed efficiency. The goal of this study was to characterize the effects of Carbadox and its withdrawal on the swine gut microbiota. Six pigs (initially 3-weeks old) received feed containing Carbadox and six received unamended feed. After 3-weeks of continuous Carbadox administration, all pigs were switched to a maintenance diet without Carbadox. DNA was extracted from feces (n = 142) taken before, during, and following (6-week withdrawal) Carbadox treatment. Phylotype analysis using 16S rRNA sequences showed the gradual development of the non-medicated swine gut microbiota over the 8-week study, and that the Carbadox-treated pigs had significant differences in bacterial membership relative to non-medicated pigs. Enumeration of fecal Escherichia coli showed that a diet change concurrent with Carbadox withdrawal was associated with an increase in the E. coli in the non-medicated pigs, suggesting that Carbadox pre-treatment prevented an increase of E. coli populations. In-feed Carbadox caused striking effects within 4 days of administration, with significant alterations in both community structure and bacterial membership, notably a large relative increase in Prevotella populations in medicated pigs. Digital PCR was used to show that the absolute abundance of Prevotella was unchanged between the medicated and non-medicated pigs despite the relative increase shown in the phylotype analysis. Carbadox therefore caused a decrease in the abundance of other gut bacteria but did not affect the absolute abundance of Prevotella. The pending regulation on antibiotics used in animal production underscores the importance of understanding how they modulate the microbiota and impact animal health, which will inform the search for antibiotic alternatives.
Dual-label quantum dot-based immunoassay for simultaneous determination of Carbadox and Olaquindox metabolites in animal tissues.[Pubmed:26775945]
Food Chem. 2016 May 15;199:70-4.
A novel and reliable dual-label direct competitive fluorescence-linked immunosorbent assay (dc-FLISA) based on quantum dots (QDs) was developed for the simultaneous determination of the major metabolites of Carbadox and Olaquindox residues in animal tissues, using anti-QCA monoclonal antibodies and anti-MQCA polyclonal antibodies labeled with QD520 and QD635, respectively. The limits of detection for QCA and MQCA were 0.05 and 0.07ng/ml, respectively. The method was used to analyze fortified samples and analyte recoveries ranged from 81.5% to 98.2% (QCA) and 84.2% to 95.7% (MQCA). Good correlations between the dc-FLISA method and HPLC were demonstrated for the determination of QCA and MQCA residues in swine tissue samples, confirming the reliability of the proposed method.
HPLC-MS/MS method validation for the detection of carbadox and olaquindox in poultry and swine feedingstuffs.[Pubmed:26452885]
Talanta. 2015 Nov 1;144:740-4.
Carbadox (CBX) and olaquindox (OLA) were used in poultry and swine feed for growth promotion, to improve feed efficiency and increase the rate of weight gain. However, the use of these agents in feedingstuffs was prohibited because of concerns about their toxicity. Regulatory laboratories are required to have suitably validated analytical methods to ensure compliance with the ban. A quantitative and confirmatory method for determining the presence of CBX and OLA in poultry and swine feed by high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) was developed, optimized, and validated. The analytes extraction was performed with a mixture of water and acetonitrile (1:1v/v) and cleanup with hexane and C18 (dispersive phase). The method was evaluated by the following parameters: specificity, linearity, matrix effect, decision limits (CCalpha), detection capability (CCbeta), accuracy, precision, limits of detection (LoD), limits of quantification (LoQ) and measurement uncertainty. The validated method presented a broad linear study range and no significant matrix effect. The limit of detection (LoD) was defined at 9 mug kg(-1) for CBX and 80 mug kg(-1) for OLA, and the limit of quantification (LoQ) was defined at 12 mug kg(-1) and 110 mug kg(-1) for CBX and OLA, respectively. The accuracy of the method was adequate for CBX and OLA. The recovery values found in the repeatability conditions were 99.41% for CBX and 104.62% for OLA. Under intralaboratory reproducibility conditions, the values were 98.63% for CBX and 95.07% for OLA. It was concluded that the performance parameters demonstrated total method adequacy for the detection and quantification of CBX and OLA in poultry and swine feedingstuffs.
In vivo studies to highlight possible illegal treatments of rabbits with carbadox and olaquindox.[Pubmed:26400201]
Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2015;32(12):1976-91.
For the treatment of rabbit dysentery and bacterial enteritis, veterinary practitioners often adopt veterinary medicinal products authorised for other food-producing species, but in some cases non-authorised drugs frequently used in the past, such as Carbadox and olaquindox, might be illegally adopted. To verify the Carbadox and olaquindox distribution and persistence in rabbit tissues, two independent in vivo studies were carried out. In the first study, 24 healthy rabbits received water medicated with Carbadox at 100 mg l(-1) over a period 28 days, whereas in the second one, 24 healthy rabbits were administered water containing olaquindox at 100 mg l(-1). In each study rabbits were randomly assigned to four groups to be sacrificed respectively at 0, 5, 10 and 20 days from treatment withdrawal, for depletion studies. A control group of six animals was adopted for control and as a reservoir of blank tissues. Muscle and liver samples collected from each treated animal were stored at -20 degrees C pending the analysis. Sensitive and robust liquid chromatography-tandem mass spectrometry analytical methods were set up for the parent compounds and their main metabolites quinoxaline-2-carboxylic acid, desoxyCarbadox and 3-methylquinoxaline-2-carboxylic acid to verify their residual. Data collected demonstrate that the combination of liver as target matrix, quinoxaline-2-carboxylic acid and 3-methylquinoxaline-2-carboxylic acid as marker residue and enzymatic digestion is strategic to evidence Carbadox and/or olaquindox illegal treatments in rabbits, even 20 days after treatment withdrawal at concentration levels higher than 0.5 microg kg(-1). This findings suggests that liver should be proposed as target matrix for official control in national monitoring plan.